asdfasdf
초대의 글
안녕하십니까!
삼성서울병원 암병원과 정밀의학혁신연구소에서 주관하는 "The 2nd Precision Oncology International Symposium"에 귀하를 초대합니다. 이번 심포지엄은 빠르게 급변하는 의료 현장에 바이오테크 기술과 임상현장의 니즈를 빠르게 접목시키기 위하여 준비하게 되었습니다.
이에 금년 심포지엄은 “The SMC - Gustave Roussy Partnership: Research Cures Cancer” 라는 주제로 관련 분야의 국내의 훌륭한 석학들을 모시고 혁신 의료기술 동향과 임상의의 교류를 통한 차세대 연구의 방향성을 토론하고자 하오니, 진료와 연구 등으로 많이 바쁘시겠지만 관심있으신 분들의 많은 참여와 성원을 부탁드립니다. 감사합니다.
2024년 2월 2일
삼성서울병원 암병원장 이우용
찾아오시는 길
주 소 : 서울 강남구 일원로 81, 삼성서울병원 암병원 B1 강당
※ 무료 주차지원이 불가능하므로 대중교통을 이용바랍니다.
프로그램
| TIME | TOPIC | CHAIR / SPEAKER |
|---|
| 08:50-09:00 (10) | Welcome Messages from SMC leadership | Seung Woo Park, MD President Samsung Medical Center |
| The Partnership between SMC & Gustave Roussy | Fabrice Barlesi, MD General Director Gustave Roussy, France Wooyong Lee, MD Director, Cancer Hospital Samsung Medical Center |
|
| Session I (09:00-10:15) |
Plenary session | Taewon Kim, MD Director, Cancer Institute, Asan Medical Center Wooyong Lee, MD Director, Cancer Hospital, Samsung Medical Center |
| 09:00-09:20 (20) | Gustave Roussy: an overview to cure cancer as an institution | Fabrice Barlesi, MD General Director Gustave Roussy, France |
| 09:20-09:45 (25) | Functional precision medicine in GI cancers | Alice Boileve, Ph.D Gustave Roussy, France |
| 09:45-10:05 (20) | Drug development from academia to clinical trials | DoHyun Nam, MD Department of Neurosurgery Samsung Medical Center CEO, AIMEDBIO, Korea |
| 10:05-10:15 (10) | Q&A | |
| Session II (10:15-11:10) |
New drug development from academia to clinical trials | Taeyou Kim, MD Past Director, Cancer Hospital Seoul National University Kyoung-Mee Kim, MD Director, Center for Experimental Pathology Samsung Medical Center |
| 10:15-10:30 (15) | Precision medicine in Gi oncology at SMC | Jeeyun Lee, MD Director Experimental Therapeutics Development Center Precision Cancer Therapeutics Center Samsung Medical Center |
| 10:30-10:45 (15) | Adoptive T cell therapy for refractory cancer patients: from concept to clinical trials | Seung Tae Kim, MD Innovative Institute for Precision Medicine Precision Cancer Therapeutics Center Division of Hematology-Oncology Samsung Medical Center |
| 10:45-11:00 (15) | AI driven drug discovery from bed to benchside | Sung Wook Seo, MD Director, Rare Cancer Center Department of Orthopedic surgery Samsung Medical Center Institute of Biomedical AI, SAIHST |
| 11:00-11:10 (10) | Q&A | |
| Session Ⅲ (11:10-12:05) |
A New Combination for Radiotherapy: Immunotherapy and Artificial Intelligence | Hee Chul Park, MD Director, Proton Therapy Center Samsung Medical Center Woo Kyoung Jeong, MD Radiology, Samsung Medical Center |
| 11:10-11:35 (25) | Gustave Roussy : Translational projects in immunoradiotherapy | Eric Deutsch, MD Oncology-radiotherapy Universiy of Paris-Saclay |
| 11:35-11:50 (15) | Deep learning-based auto-segmentation of target volume | Jae Myoung Noh, MD Department of Radiation Oncology Samsung Medical Center |
| 11:50-12:05 (15) | Experience in clinical trials combining Immunotherapy and radiotherapy | Hee Chul Park, MD Director, Proton Therapy Center Department of Radiation Oncology Samsung Medical Center |
| 12:05-13:00 (55) | Lunch break | |
| Session Ⅳ (13:00-14:40) |
Translation Oncology: from bench-side to patients | Joon Oh Park, MD Director, Innovative Institute for Precision Medicine Samsung Medical Center Yong Han Paik, MD Director, Liver Cancer Center Samsung Medical Center |
| 13:00-13:25 (25) | From concept to implementation : 15 years of precision medicine program of Gustave Roussy | Pr Fabrice André Director of Research Gustave Roussy, France |
| 13:25-13:50 (25) | Precision medicine is finally becoming the reality in prostate cancer | Pr Karim Fizazi Head of International Academic Network Gustave Roussy, France |
| 13:50-14:05 (15) | Insights from healthcare big data for sustainable, long-term cancer control | Jung Yong Hong, MD Future Medicine X Center Precision Cancer Therapeutics Center Division of Hematology-Oncology Samsung Medical Center |
| 14:05-14:20 (15) | Spatiotemporally Resolved Single-cell Analyses Delineate Early Esophageal Squamous Carcinogenesis | Byung-Hoon Min, MD Gastric Cancer Center Division of Gastroenterology Samsung Medical Center |
| 14:20-14:40 (20) | Q&A and coffee break | |
| Session Ⅴ (14:40-15:50) |
Translation Oncology: from bed to bench-side | Nooli Jeon, Ph.D Department of Mechanical Engineering Seoul National University YoungSuk Park, MD Samsung Medical Center |
| 14:40-14:55 (15) | Application of 3D Printing-Assisted Tumor Microenvironment in Translational Oncology | Sujin Hyung, Ph.D Senior Scientist Innovative Institute for Precision Medicine Samsung Medical Center |
| 14:55-15:10 (15) | Innovations in liver surgery and the potential role of surgeons on precision medicine | Jinsoo Rhu, MD Future Medicine X Center Precision Cancer Therapeutics Center Division of Transplantation Surgery, General Surgery Samsung Medical Center |
| 15:10-15:25 (15) | Therapeutic targeting of the tumor microenvironment in colorectal cancer | Yong Beom Cho, MD Director, Colorectal Cancer Director, Drug Screening Research Center, IIPM Division of Colon and Rectal Surgery Samsung Medical Center |
| 15:25-15:35 (10) | Dynamics of tumor specific-T cells in diverse immune landscape in advanced gastric cancer | Minae An, Ph.D Experimental Therapeutics Development Center IIPM Samsung Medical Center |
| 15:35-15:50 (15) | Closing Remark | Wooyong Lee, MD Director, Cancer Hospital Samsung Medical Center |
| Panel discussion for Collaborative Work | ||
강연 시청